The only Ferrari Driver Academy member to win a championship this year will not be part of its programme in 2024.
Formula 2 driver Arthur Leclerc, the younger brother of Ferrari’s Formula 1 ace Charles Leclerc, will also leave the FDA. The younger Leclerc joined the scheme in 2020 and finished 15th in his first season in F2 this year.
Oliver Bearman, who accompanied Leclerc in promotion from Formula 3 this year, enjoyed a more successful season, winning four times on his way to sixth in the standings. The team described him as the “outstanding FDA star” of 2023. Bearman also had his first run in an F1 car for Ferrari and drove for Haas in test and practice sessions.
Dino Beganovic will also remain an FDA member having finished sixth in his first season in Formula 3. Ferrari say he is “expected to be a title contender next year.”
Formula Regional racers Rafael Camara and Maya Weug, plus Formula 4 pair Tuukka Taponen and Aurelia Nobels, complete the slimmed-down six-driver FDA squad for 2024. Camara placed fifth in the European Formula Regional series and the team named him as another third driver they expect to fight for a title.
Taponen took fifth in the Italian Formula 4 series, one place behind Wharton. Nobels suffered a disrupted season after injuring her arm in an incident in the pit lane during the series’ Misano round, forcing her to miss the following event at Spa-Francorchamps.
There will also be a change at the top of the FDA next year following the departure of Marco Matassa. Jock Clear, who was Charles Leclerc’s performance engineer this year, will take charge for Ferrari’s young driver programme.
Advert | Become a RaceFans supporter and
- Pictures: Formula 2’s colourful new-look field for 2024
- New qualifying red flag rule will stop drivers “ruining the session for everyone else”
- F2 racer Crawford joins Aston Martin’s young driver programme
- Barnard completes Formula 2 grid by joining PHM
- Sauber hires former Red Bull junior Maloney as reserve driver